Ignite Creation Date:
2024-05-06 @ 3:08 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04535713
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2020-08-27
Brief Title:
GALLANT Metronomic Gemcitabine Doxorubicin Docetaxel and Nivolumab for Advanced Sarcoma
Sponsor:
Sarcoma Oncology Research Center LLC
Organization:
Sarcoma Oncology Research Center LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-30
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-08-27
First Submit QC Date:
August 27 2020
Study First Post Date:
2020-09-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-02
Last Update Post Date:
2024-07-05
Last Update Post Date Type:
ACTUAL